Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

 

Cleveland Clinic Rheumatology
Avatar

Revisiting Anti-TNF 20 Years Later

By Cleveland Clinic Rheumatology FEATURING John Looney
By Cleveland Clinic Rheumatology FEATURING John Looney
87 views
January 15, 2019
0 Comments
Login to view comments. Click here to Login
RA
54:18
John Tesser

Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogene…

20:34
Cleveland Clinic Rheumatology

CVD in RA: Need for Management of CVD in RA, CV Risk Calculation &am…

Feat. W. Rigby
29:07
Cleveland Clinic Rheumatology

RA: Use of Imaging to Predict Transition to RA, the Changing Landsca…

Feat. W. Rigby
20:18
Cleveland Clinic Rheumatology

Red Eye in RA: What Is the Differential Diagnosis in General and in …

Feat. J. Rosenbaum
15:06
Cleveland Clinic Rheumatology

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? …

Feat. J. Parambil
Cleveland Clinic Rheumatology

Interstitial Lung Disease: What Are the Most Important Advances in C…

Feat. J. Parambil
10:45
Cleveland Clinic Rheumatology

Connective Tissue Disease-Associated Interstitial Lung Disease: Why …

Feat. J. Parambil
07:12
Cleveland Clinic Rheumatology

Tapering vs. Continuing Glucocorticoids in RA: Do Autoantibody Level…

Feat. A. Kavanaugh, J. Cush
05:34
Cleveland Clinic Rheumatology

bDMARDs and nbDMARDs in RA: Is VTE a Clinical Concern in RA?

Feat. A. Kavanaugh, J. Cush
05:59
Cleveland Clinic Rheumatology

Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in…

Feat. A. Kavanaugh, J. Cush
12:33
Cleveland Clinic Rheumatology

RA & 8 TNFi Biosimilars Efficacy Analysis: Can Multiple bDMARD S…

Feat. A. Kavanaugh, J. Cush
07:54
Cleveland Clinic Rheumatology

bDMARDS in RA: Why Do Patients With Low Levels of 1st TNFi Respond B…

Feat. A. Kavanaugh, J. Cush
08:31
Cleveland Clinic Rheumatology

Refractory Pain in Early RA: What Are the Alternative Treatment Stra…

Feat. A. Kavanaugh, J. Cush
20:57
Cleveland Clinic Rheumatology

IMIDs & Vaccines Update: What Are the Updated Immunization Recom…

Feat. C. Calabrese
05:59
Cleveland Clinic Rheumatology

Rheumatology – Oncology: Cases with the Masters

Feat. L. Calabrese, V. Velcheti
30:39
Cleveland Clinic Rheumatology

T Cell Subsets Overview: Is TH1 Critically Important for Killing Fac…

Feat. J. Looney
24:57
Cleveland Clinic Rheumatology

Links Between Chronic Inflammation and Atherosclerotic Disease and E…

Feat. E. Husni
09:20
Cleveland Clinic Rheumatology

Cardiovascular Risk on RA and PsA Patients: What are the Most Common…

Feat. E. Husni
30:51
Cleveland Clinic Rheumatology

Human Behavior and Immunity – Slowing Aging?

Feat. L. Calabrese
07:40
Cleveland Clinic Rheumatology

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…

Feat. C. Calabrese
22:30
Cleveland Clinic Rheumatology

Immune Related Adverse Events from Cancer Immunotherapy: The Role of…

Feat. C. Calabrese
Cleveland Clinic Rheumatology

Cases with the Masters Discussion: Vasculitis, Co-morbidities, Rheum…

Feat. J. Looney, C. Calabrese
14:45
Cleveland Clinic Rheumatology

Case Review of 40-Year-Old Male HIV-infected Patient With Severe Pol…

Feat. J. Looney, C. Calabrese
41:07
Cleveland Clinic Rheumatology

Cases with the Masters: Clinical Challenges in Rheumatoid Arthritis

Feat. L. Calabrese, E. Keystone, A. Kavanaugh, I. Mcinnes, J. Kay, J. Cush
18:57
Cleveland Clinic Rheumatology

Targeting the IL1 Family in Autoimmune and Autoinflammatory Diseases

Feat. J. Looney
50:27
Cleveland Clinic Rheumatology

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheu…

Feat. A. Kavanaugh, J. Cush
29:26
Cleveland Clinic Rheumatology

Predicting Outcomes in RA - The Role of Biomarkers

Feat. J. Kay
53:53
Cleveland Clinic Rheumatology

Pre-Rheumatoid Arthritis: Can We Define It and Prevent Its Progressi…

Feat. M. Holers
45:10
Cleveland Clinic Rheumatology

Cytokine Profiles in Health and Disease

Feat. I. Mcinnes
37:02
Cleveland Clinic Rheumatology

Increased Inflammation and Disease Activity Among Current Cigarette …

Feat. T. Mikuls
32:24
Cleveland Clinic Rheumatology

IgA Plasmablasts Are Evaluated in Subjects at Risk for Future Rheuma…

Feat. L. Calabrese, M. Holers
32:50
Cleveland Clinic Rheumatology

Advances in Rheumatoid Arthritis

Feat. W. Rigby
16:17
Cleveland Clinic Rheumatology

PPACMAN Update (Rheumatology/Dermatology)

Feat. J. Merola
19:34
Cleveland Clinic Rheumatology

Preventing Infections in Patients Treated with Biologics

Feat. C. Calabrese
23:36
Cleveland Clinic Rheumatology

Revisiting Anti-TNF 20 Years Later

Feat. J. Looney
16:50
Cleveland Clinic Rheumatology

T-Cell and B-Cell (and Other) Targeting in IMIDs

Feat. G. Silverman
17:28
Cleveland Clinic Rheumatology

IL6 Targeting

Feat. L. Calabrese
24:08
Cleveland Clinic Rheumatology

Tailoring Therapy Based on Disease Duration: Is There A Window of Op…

Feat. E. Keystone
26:10
Cleveland Clinic Rheumatology

Predicting the Outcome of Treatment De-Escalation or Discontinuation…

Feat. A. Kavanaugh
30:39
Cleveland Clinic Rheumatology

Herpes Zoster and the Risk of Stroke in Patients with Autoimmune Dis…

Feat. L. Calabrese, C. Calabrese
60:16
Cleveland Clinic Rheumatology

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

Feat. L. Calabrese
21:51
Cleveland Clinic Rheumatology

Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizum…

Feat. L. Calabrese, M. Jani